$3.75
-0.04 (-1.06%)
Open$3.68
Previous Close$3.79
Day High$3.91
Day Low$3.68
52W High$11.68
52W Low$3.42
Volume—
Avg Volume10.9K
Market Cap46.07M
P/E Ratio—
EPS$-1.12
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+820.3% upside
Current
$3.75
$3.75
Target
$34.51
$34.51
$26.32
$34.51 avg
$56.88
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 2.50M | 2.18M | 21.69M |
| Net Income | -12,238,584 | -9,613,131 | 2.61M |
| Profit Margin | -490.0% | -465.5% | 12.0% |
| EBITDA | -12,104,829 | -10,036,295 | 4.63M |
| Free Cash Flow | — | — | 2.95M |
| Rev Growth | +14.6% | +14.6% | +19.5% |
| Debt/Equity | 0.03 | 0.03 | 0.66 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |